Center variation in the use of nonstandardized model for end-stage liver disease exception points.
about
Advances in liver transplantation allocation systemsVariable Use of Model for End-Stage Liver Disease Exception Points in Patients With Neuroendocrine Tumors Metastatic to the Liver and Its Impact on Patient Outcomes.United Network for Organ Sharing regional variations in appeal denial rates with non-standard Model for End-Stage Liver Disease/Pediatric End-Stage Liver Disease exceptions: support for a national review board.Center differences in model for end-stage liver disease exceptions: fairness, local culture, and norms of practice.Disparities in Waitlist and Posttransplantation Outcomes in Liver Transplant Registrants and Recipients Aged 18 to 24 Years: Analysis of the UNOS Database.The Current State of Liver Transplantation in the United States: Perspective From American Society of Transplant Surgeons (ASTS) Scientific Studies Committee and Endorsed by ASTS Council.Sociodemographic Determinants of Waitlist and Posttransplant Survival Among End-Stage Liver Disease Patients.Racial and ethnic disparities in access to and utilization of living donor liver transplants.Use of model for end-stage liver disease exceptions for donation after cardiac death graft recipients relisted for liver transplantation.Waitlist Outcomes for Patients Relisted Following Failed Donation After Cardiac Death Liver Transplant: Implications for Awarding Model for End-Stage Liver Disease Exception Scores.
P2860
Q26766076-7BCBB5F3-90C0-4B72-B329-7AAA4D317E6CQ36284669-B0D55CB4-AD43-4824-A169-227BB6876A04Q37225010-53B75DC4-3420-4E01-82AF-65D1D64B1B03Q37351296-FA688FC9-9A63-4A43-84F2-26F99A2D7AD9Q38754147-1AED523F-AD1A-493C-A48E-725793472A78Q38804947-C49CB975-86B8-4924-8C33-BF767764D6E6Q40127851-92A237C8-E314-4E23-9B83-260CD79A56FFQ40271644-8FB2B64D-E472-4BC9-A25F-06BD75E76F6FQ41569248-1AFFC360-253E-4BAC-8411-0276B00148C6Q50615861-08D90907-4A03-4E37-B265-72997E9AF93A
P2860
Center variation in the use of nonstandardized model for end-stage liver disease exception points.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Center variation in the use of ...... iver disease exception points.
@en
Center variation in the use of ...... iver disease exception points.
@nl
type
label
Center variation in the use of ...... iver disease exception points.
@en
Center variation in the use of ...... iver disease exception points.
@nl
prefLabel
Center variation in the use of ...... iver disease exception points.
@en
Center variation in the use of ...... iver disease exception points.
@nl
P2093
P2860
P356
P1476
Center variation in the use of ...... iver disease exception points.
@en
P2093
Benjamin French
David S Goldberg
George Makar
Therese Bittermann
P2860
P304
P356
10.1002/LT.23732
P577
2013-10-10T00:00:00Z